What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Cognition
His scientific interests lie mostly in Atrophy, Alzheimer's disease, Neuroscience, Positron emission tomography and Hippocampal formation.
Renaud La Joie combines subjects such as Cognition, Neuropsychological test, Disease, Biomarker and Pediatrics with his study of Atrophy.
His research integrates issues of Psychiatry, Dementia, Posterior cortical atrophy, Dysexecutive syndrome and Primary progressive aphasia in his study of Alzheimer's disease.
As part of one scientific family, he deals mainly with the area of Dementia, narrowing it down to issues related to the Hippocampus, and often Neuroimaging, Pathological, β amyloid and Cortex.
His work deals with themes such as Youden's J statistic and Pathology, which intersect with Positron emission tomography.
His work on Subiculum as part of general Hippocampal formation study is frequently linked to Anatomical space, therefore connecting diverse disciplines of science.
His most cited work include:
- Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia. (221 citations)
- The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. (216 citations)
- Quantitative Comparison of 21 Protocols for Labeling Hippocampal Subfields and Parahippocampal Subregions in In Vivo MRI: Towards a Harmonized Segmentation Protocol (209 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Disease, Neuroscience, Pathology, Atrophy and Neuroimaging.
His Cognition research extends to the thematically linked field of Disease.
His work carried out in the field of Neuroscience brings together such families of science as Alzheimer's disease and Semantic dementia.
His Alzheimer's disease research is multidisciplinary, incorporating elements of Standardized uptake value, Posterior cingulate and Frontotemporal dementia.
The study incorporates disciplines such as Default mode network and Grey matter in addition to Atrophy.
The various areas that Renaud La Joie examines in his Neuroimaging study include Biomarker and Pathological.
He most often published in these fields:
- Disease (38.15%)
- Neuroscience (33.53%)
- Pathology (22.54%)
What were the highlights of his more recent work (between 2019-2021)?
- Disease (38.15%)
- Neuroimaging (22.54%)
- Pathology (22.54%)
In recent papers he was focusing on the following fields of study:
Renaud La Joie spends much of his time researching Disease, Neuroimaging, Pathology, Internal medicine and Dementia.
His Disease study combines topics in areas such as Distribution and Atrophy.
His Neuroimaging research is within the category of Neuroscience.
As part of the same scientific family, Renaud La Joie usually focuses on Pathology, concentrating on Standardized uptake value and intersecting with Neurofibrillary tangle.
His Internal medicine research includes elements of Neurology and Oncology.
His biological study spans a wide range of topics, including Positron emission tomography, Hyperintensity and Cognition, Cognitive impairment.
Between 2019 and 2021, his most popular works were:
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. (123 citations)
- Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET (90 citations)
- A molecular gradient along the longitudinal axis of the human hippocampus informs large-scale behavioral systems (29 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Cognition
Renaud La Joie mostly deals with Dementia, Pathology, Disease, Positron emission tomography and Alzheimer's disease.
Dementia is the subject of his research, which falls under Internal medicine.
His study looks at the intersection of Internal medicine and topics like Oncology with Precision medicine.
His biological study deals with issues like Standardized uptake value, which deal with fields such as Neurofibrillary tangle, Pittsburgh compound B and Medical diagnosis.
His study in Disease is interdisciplinary in nature, drawing from both Inflammation, Cognition and Atrophy.
His studies in Amyloid integrate themes in fields like Apolipoprotein E and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
